Extracellular Vesicle Uptake Assay via Confocal Microscope Imaging Analysis
February 14th, 2022
Extracellular vesicles (EVs) contribute to cellular biology and intercellular communications. There is a need for practical assays to visualize and quantify EVs uptake by the cells. The current protocol proposes the EV uptake assay by utilizing three-dimensional fluorescence imaging via confocal microscopy, following EV isolation by a nano-filtration-based microfluidic device.
Overview
This study addresses the need for effective assays to visualize and quantify the uptake of extracellular vesicles (EVs) by cells. Utilizing a nano-filtration-based microfluidic device and 3D fluorescence imaging via confocal microscopy, the protocol enables the analysis of EV uptake, which can provide insights into intercellular communication.
Key Study Components
Research Area
- Extracellular vesicles (EVs)
- Intercellular communication
- Cancer biology and drug delivery
Background
- EVs play a crucial role in cellular biology and communication.
- There is a need for practical methodologies to measure EV uptake.
- Understanding EV dynamics can aid in therapeutic applications.
Methods Used
- 3D fluorescence imaging via confocal microscopy
- PC3 cells as a model system
- Nano-filtration-based microfluidic device for EV isolation
Main Results
- Quantification of internalized EVs using volumetric analysis.
- Demonstrated that the uptake level depends on incubation time.
- Systematic exclusion of non-internalized EVs enhances accuracy.
Conclusions
- The study provides a reliable protocol for analyzing EV uptake.
- This method has implications for studies in cancer therapy and drug delivery.
Frequently Asked Questions
Executive Industry Relevance
Quantitative analysis of extracellular vesicle (EV) uptake is critical for de-risking cell communication hypotheses and advancing EV-based therapeutic strategies. This confocal imaging assay enables precise discrimination between internalized and superficial EVs, supporting predictive confidence in early discovery and translational research. The methodology enhances portfolio decision-making by providing robust, reproducible uptake metrics for candidate evaluation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables rigorous interrogation of EV-mediated intercellular signaling pathways.
- Supports biological de-risking by distinguishing true cellular uptake from surface association.
- Provides quantitative uptake data to inform target validation and mechanistic studies.
Screening & Assay Development
- Delivers standardized, reproducible 3D confocal imaging outputs for assay development.
- Facilitates preparation of validated cellular systems for downstream compound screening.
- Enables high-content, quantitative readouts suitable for scalable screening workflows.
Translational & Preclinical Research
- Aligns EV uptake quantification with disease-relevant models in oncology and drug delivery.
- Supports translational continuity by enabling real-time tracking and spatial analysis of EV trafficking.
- Provides data for risk-adjusted advancement of EV-based therapeutic candidates.
Pipeline & Workflow Integration
This assay integrates into the discovery-to-preclinical continuum, bridging early mechanistic studies with translational evaluation of EV-based modalities.
- Discovery Biology: Quantifies EV internalization to clarify intercellular communication mechanisms.
- Screening: Supplies reproducible, quantitative uptake metrics for assay readiness and compound evaluation.
- Analytics: Generates volumetric and spatial data to compare uptake across experimental conditions.
- Translational Research: Enables real-time, 3D tracking of EVs in disease-relevant cellular systems.
- Enterprise Reuse: Establishes a standardized workflow adaptable across cell types and research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces ambiguity in EV uptake studies.
- Operational Value: Enhances assay standardization, reproducibility, and scalability for R&D teams.
- Strategic Value: Informs go/no-go decisions and optimizes resource allocation in EV-based portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization of EV-targeted therapeutic programs.
Implementation Considerations
- Requires expertise in confocal microscopy and advanced image analysis software.
- Demands access to microfluidic EV isolation devices and fluorescence labeling reagents.
- Necessitates cross-team standardization of imaging and analysis parameters.
- Adaptable to various cell lines with appropriate optimization of labeling and imaging conditions.
- Dependent on robust exclusion of non-internalized EVs for accurate quantification.
Biopharma FAQs
Chapters in this video
0:04
Introduction
1:15
Extracellular Vesicle (EV) Isolation and On-Chip Immuno-Fluorescent Labeling
2:54
Incubation of the Cells with Fluorescently Labeled EVs for the EV-Uptake Assay
3:45
Confocal Microscopy and Image Processing
6:28
Results: EV Uptake Assay Using 3D Fluorescence Imaging via Confocal Microscopy
7:31
Conclusion
